Episode 4: Marianne Clancy, Executive Director at Cure HHT

Episode 4 June 23, 2021 00:38:12
Episode 4:  Marianne Clancy, Executive Director at Cure HHT
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 4: Marianne Clancy, Executive Director at Cure HHT

Jun 23 2021 | 00:38:12

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Marianne Clancy, Executive Director at Cure HHT, about the foundation and their goal of reducing the number of undiagnosed cases of HHT.

Other Episodes

Episode 13

October 27, 2021 00:50:12
Episode Cover

Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime

How has patient advocacy grown to become the driver of rare disease drug development? In today's episode of Biorasi's Few & Far Between podcast,...

Listen

Episode 54

May 28, 2025 00:45:11
Episode Cover

Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

The challenge? Decoding the human immune system. Get ready to meet the top challenger on today's episode of the Biorasi Few & Far Between...

Listen

Episode 39

March 26, 2024 00:45:10
Episode Cover

Episode 39: Dr. Keith Flaherty, Director of Clinical Research at Massachusetts General Hospital Cancer Center

"Technologies have changed enormously in terms of how we can basically procure, preserve, and then interrogate a tumor specimen...like effectively in real time, like...

Listen